Pasithea Therapeutics Corp Share Price: KTTA (Pasithea Therapeutics Corp) Stock Price Today & Updates | INDmoney

Question 1

What is Pasithea Therapeutics Corp share price today?

Accepted Answer

Pasithea Therapeutics Corp (KTTA) share price today is {{live_price}}.

Question 2

Can Indians buy Pasithea Therapeutics Corp shares?

Accepted Answer

Yes, Indians can invest in the Pasithea Therapeutics Corp (KTTA) from India.

With INDmoney, you can buy Pasithea Therapeutics Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pasithea Therapeutics Corp at zero transaction cost.

Question 3

How can I buy Pasithea Therapeutics Corp shares from India?

Accepted Answer

It is very easy to buy Pasithea Therapeutics Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Pasithea Therapeutics Corp be purchased?

Accepted Answer

Yes, you can buy fractional shares of Pasithea Therapeutics Corp with INDmoney app.

Question 5

What are the documents required to start investing in Pasithea Therapeutics Corp stocks?

Accepted Answer

To start investing in Pasithea Therapeutics Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Pasithea Therapeutics Corp

Accepted Answer

Today’s highest price of Pasithea Therapeutics Corp (KTTA) is {{1_rba_end}}.

Today’s lowest price of Pasithea Therapeutics Corp (KTTA) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Pasithea Therapeutics Corp

Accepted Answer

Today's market capitalisation of Pasithea Therapeutics Corp KTTA is 6.9M

Question 8

What is the 52 Week High and Low Range of Pasithea Therapeutics Corp

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Pasithea Therapeutics Corp is down from its 52 Week High?

Accepted Answer

Pasithea Therapeutics Corp (KTTA) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Pasithea Therapeutics Corp is up from its 52 Week low?

Accepted Answer

Pasithea Therapeutics Corp (KTTA) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Pasithea Therapeutics Corp?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Pasithea Therapeutics Corp

Accepted Answer

Dr. Lawrence  Steinman BA, M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pasithea Therapeutics Corp.

Period	Pasithea Therapeutics Corp	Index (Russel 2000)
3 Months	-8.28%	0.0%
6 Months	10.06%	0.0%
1 Year	-2.89%	0.0%
3 Years	-90.73%	-20.1%

Market Capitalization	6.9M
Book Value	$22.46
Earnings Per Share (EPS)	-12.64
Wall Street Target Price	2.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-28.02%
Return On Equity TTM	-47.07%

Revenue TTM	486.6K
Revenue Per Share TTM	0.37
Quarterly Revenue Growth YOY	1498.1%
Gross Profit TTM	-2.2K
EBITDA	-15.3M
Diluted Eps TTM	-12.64
Quarterly Earnings Growth YOY	0.0

Pasithea Therapeutics Corp (KTTA)

Increasing Revenue

Increasing Net Profit

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pasithea Therapeutics Corp	-2.31%	10.06%	-2.89%	-90.73%	-90.73%
Moderna, Inc.	37.56%	83.82%	13.37%	-12.47%	553.14%
Regeneron Pharmaceuticals, Inc.	10.42%	24.29%	32.26%	98.6%	210.52%
Novo Nordisk A/s	7.9%	30.89%	58.53%	230.87%	458.51%
Vertex Pharmaceuticals Incorporated	10.52%	25.13%	30.01%	109.26%	156.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pasithea Therapeutics Corp	NA	NA	NA	0.0	-0.47	-0.28	NA	22.46
Moderna, Inc.	24.73	NA	0.0	-6.46	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	29.16	29.16	1.46	44.2	0.15	0.08	NA	250.15
Novo Nordisk A/s	45.83	45.83	2.36	3.5	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	28.9	28.9	0.53	17.11	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pasithea Therapeutics Corp	Buy	$6.9M	-90.73%	NA	0.0%
Moderna, Inc.	Buy	$54.0B	553.14%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$108.8B	210.52%	29.16	29.45%
Novo Nordisk A/s	Buy	$592.1B	458.51%	45.83	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$115.1B	156.43%	28.9	39.46%

Organization	Pasithea Therapeutics Corp
Employees	8
CEO	Dr. Lawrence Steinman BA, M.D., Ph.D.
Industry	Miscellaneous